FDA Issues Guidance on Regulation of Mosquito-Related Products
The Food and Drug Administration released a guidance document to clarify FDA and Environmental Protection Agency jurisdiction over mosquito-related products. According to the guidance document, FDA’s definition of drug “does not include articles intended to function as pesticides by preventing,…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
destroying, repelling, or mitigating mosquitoes for population control purposes.” Rather, “products intended to reduce the population of mosquitoes (for example, by killing them at some point in their life cycle, or by interfering with their reproduction or development)” are examples of pesticides regulated by EPA, the guidance document said. “FDA encourages sponsors of mosquito-related products, other than those that are intended to prevent, destroy, repel, or mitigate mosquitoes by controlling a mosquito population, to contact FDA early in the development process,” it said. In cases of jurisdictional questions, FDA and EPA will consult with each other and may suggest a joint meeting with the product’s sponsor, FDA said.